Jafron Biomedical Co.,Ltd. (SHE:300529)

Jafron Biomedical Revenue

Jafron Biomedical had revenue of 560.62M CNY in the quarter ending March 31, 2026, with 2.33% growth. This brings the company's revenue in the last twelve months to 2.02B, down -18.39% year-over-year. In the year 2025, Jafron Biomedical had annual revenue of 2.01B, down -24.86%.

• Revenue (ttm): 2.02B
• Revenue Growth: -18.39%
• P/S Ratio: 7.44
• Revenue / Employee: 879.88K
• Employees: 2,301
• Market Cap: 15.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.01B	-665.50M	-24.86%
Dec 31, 2024	2.68B	754.97M	39.27%
Dec 31, 2023	1.92B	-569.09M	-22.84%
Jan 1, 2023	2.49B	-184.02M	-6.88%
Jan 1, 2022	2.68B	724.67M	37.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 15, 2026

Data Sources Report a data error